Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Is endothelial dysfunction induced by aromatase inhibitors reversible after treatment?
Journal: Breast cancer research and treatment
Published: March 22, 2026
Presence of Clonal Hematopoiesis and Cardiac Events After Allogeneic Stem Cell Transplantation.
Journal: Journal of the American Heart Association
Published: September 19, 2025
Corrigendum to "Atrial fibrillation in cancer, anticancer therapies, and underlying mechanisms" [Journal of Molecular and Cellular Cardiology. 194 (2024): 118-132].
Journal: Journal of molecular and cellular cardiology
Published: July 05, 2025
BRASH syndrome: A rare but reversible cause of sinus node dysfunction.
Journal: HeartRhythm case reports
Published: July 10, 2024
Cardiotoxic Atrial Fibrillation With Novel Cancer Treatment: More Relevant Than We Think.
Journal: JACC. Advances
Published: June 28, 2024
Pembrolizumab-Induced Smoldering Myocarditis in Patients With Triple-Negative Breast Cancer.
Journal: JACC. Case reports
Published: June 23, 2024
Cardiovascular toxicities associated with bispecific T-cell engager therapy.
Journal: Journal for immunotherapy of cancer
Published: January 22, 2024
Atrial fibrillation in cancer, anticancer therapies, and underlying mechanisms.
Journal: Journal of molecular and cellular cardiology
Published: November 02, 2023
Direct current cardioversion practices following percutaneous left atrial appendage closure.
Journal: Journal of cardiovascular electrophysiology
Published: April 26, 2023
Endothelial Dysfunction in Breast Cancer Survivors on Aromatase Inhibitors: Changes over Time.
Journal: Research square
Published: April 17, 2023
Last Updated: 09/26/2026